Northeast Financial Consultants Inc Charles River Laboratories International, Inc. Transaction History

Northeast Financial Consultants Inc

  • $2.25 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$182.44 - $250.54 $50,900 - $69,900
279 Added 15.55%
2,073 $408,000
Q2 2022

Aug 12, 2022
BUY
$204.13 - $302.4 $63,688 - $94,348
312 Added 21.05%
1,794 $384,000
Q1 2022

May 12, 2022
BUY
$255.51 - $362.11 $98,371 - $139,412
385 Added 35.1%
1,482 $421,000
Q4 2021

Feb 11, 2022
BUY
$351.38 - $448.68 $385,463 - $492,201
1,097 New
1,097 $413,000

Others Institutions Holding CRL

# of Institutions
698
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email